Biological Industries MSC Go hMSC differentiation kits

Wednesday, 04 February, 2015


Biological Industries (BI) has launched innovative hMSC differentiation kits for research and stem-cell-based therapies. The serum- and xeno-free differentiation kits provide the ability to efficiently differentiate hMSC from various sources into adipocytes, chondrocytes and osteoblasts.

The kits include: the MSC Go Osteogenic XF - rapid osteogenic differentiation (complete, ready to use); MSC Go Adipogenic XF - basal medium and supplements mix; and MSC Go Chondrogenic XF - basal medium and supplement mix. The differentiation media contain all the growth factors and supplements necessary for the direct differentiation of hMSC.

The kits are designed to be user-friendly, with all necessary ingredients included. They offer a complete system for multipotency evaluation and induction of hMSCs into adipocytes, chondrocytes and osteoblasts/osteocytes. No adaptation is required from cell expansion cultures using the MSC NutriStem XF Medium.

The kits were validated for hMSC from various tissues including BM-hMSC, AT-hMSC and UCT-hMSC.

Related Products

Takara Bio PrimeCap T7 RNA Polymerase (low dsRNA)

The polymerase is designed to remove both the technical and financial barriers to the successful...

Maxwell Biosystems MaxTwo high-density microelectrode array (HD-MEA) system

The next-generation multiwell HD-MEA captures high-quality signals at subcellular resolution from...

Enzo Life Sciences PROTEOSTAT Protein refolding and aggregation sensing kit

The kit includes a comprehensive set of optimised screening reagents and conditions that...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd